Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for paraquat poisoning
IRCT20220307054208N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of thalidomide in Paraquat poisoning (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Malondialdehyde measurement, Glutathione content measurement and 3 more. Started Mar 2022; status: completed.
02
Drugs
thalidomide
03
Conditions
Paraquat poisoning
Beyond the preview
Go deeper on IRCT20220307054208N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220307054208N1.